axlr_logo-2022_HD_bleudeprusseaxlr_logo-2022_HD_bleudeprusseaxlr_logo-2022_HD_bleudeprusseaxlr_logo-2022_HD_bleudeprusse

  • SATT AxLR
    • SATT AxLR
    • Governance
    • Services for companies
    • Annual reports
  • Assisting you
    • Researchers
      • Call-for-projects
    • Companies
    • Startups
    • Practical guide
  • Technology offerings
    • Invest
      • In our technologies
      • In our startups
    • Technologies
    • Startups
    • AxLR TV
  • Working with AxLR
    • Purchasing & public procurement
    • Join us
    • Our startups are hiring
  • Media
    • News
    • Agenda
    • Press kit
    • Communication kit
  • Contact
English
  • French
✕
  • Home
  • DIVINS
TCPase Inhibitors
5 May 2019
NODIA
3 May 2019

DIVINS

DIVINS

innovative implantable medical device for endovascular treatment of cerebral aneurysms

Startup

Desired partnership(s)

  • Start-up

IP

  • Patent

Establishment(s)

  • CHU Montpellier
  • University of Montpellier
  • CNRS

Laboratory(ies)

  • Laboratory of Mechanics and Civil Engineering (LMGC)

Keywords

  • Aneurysms

Co-financed by

Context

Cerebral aneurysms, notably those with a wide neck, are difficult to treat: the endovascular devices currently offered to patients are not always appropriate and may sometimes lead to delayed rupture.

Benefits

The DIVINS project offers an innovative device that combines several advantageous properties to enable better handling of intracranial aneurysms. This endovasucular prosthesis combines a flow diversion technology with stent technology to create a single, unique device that can be implanted more quickly and easily than existing devices.

Applications

Cerebral aneurysms

START-UP I Aneurysms

Share
4

Related posts

8 September 2021

StabCFTR


En savoir +
6 July 2021

HTLV-1


En savoir +
30 June 2021

REEFPULSE


En savoir +
© 2022, AxLR - SATT Occitanie Méditerranée. All rights reserved. | Legal terms & Privacy policy
English
  • English
  • French